Servier France in the news
pharma innovation research patient
Tamtam found 9 recent articles about Servier France.
- Join us on a journey that truly matters.
Servier's employee shares their journey in pharmaceutical research, highlighting personal growth, patent work, patient-centered focus, and a supportive, collaborative work environment.
- Santé. Traitements contre le cancer : le groupe français Servier rachète la société américaine Day One
Servier acquired Day One Biopharmaceuticals for $2.5 billion, strengthening its oncology focus and gaining the pediatric brain tumor drug Ojemda.
- DAWN Stock Jumps 66% on $2.5B Buyout Offer From Servier
Servier is acquiring Day One Biopharmaceuticals for $2.5 billion to bolster its oncology portfolio with Ojemda and other drug candidates.
- Servier snaps up cancer biotech Day One in $2.5bn deal
Acquisition of Day One Biopharmaceuticals for $2.5 billion to expand the oncology portfolio with the brain cancer drug Ojemda.
- Servier Boosts Presence in Rare Cancers With $2.5B Acquisition of Day One Biopharma
Servier is expanding its oncology pipeline through a $2.5 billion acquisition of Day One Biopharmaceuticals to secure new pediatric brain cancer therapies.
- Le groupe Servier, présent dans le Loiret, en forte croissance
Servier is reporting strong growth and accelerating its transition toward oncology and rare disease innovation while maintaining its leadership in cardio-metabolism.
- Le groupe Servier, présent dans le Loiret, en forte croissance
Servier is reporting strong growth driven by a strategic pivot to oncology and rare diseases while maintaining significant industrial investment in France.
- Le groupe Servier, présent dans le Loiret, en forte croissance
Servier's strong growth is driven by its focus on innovation, rare diseases, and cancer research, supported by strategic divestments and AI-driven acceleration of drug development.
- Pharma firm Servier ordered to pay millions over deadly Mediator drug
A French appeals court ordered Servier to pay over €415 million in damages for aggravated fraud and involuntary manslaughter related to its deadly Mediator drug.
Articles collected by Tamtam and kept when they are about the company, newest first. Each links to its source.
Selling to companies like Servier France?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies